September 17, 2024 Experience MBX Biosciences $188 million IPO The shares are listed on the Nasdaq Global Select Market
September 16, 2024 Experience W.W. Grainger $500 million notes offering The investment-grade notes are due 2034
September 16, 2024 Experience Terns Pharmaceuticals $173 million stock and pre-funded warrants offering The shares are listed on the Nasdaq Global Select Market
September 16, 2024 Experience Ionis Pharmaceuticals $500.3 million follow-on offering The shares are listed on the Nasdaq Global Select Market
September 16, 2024 Experience PG&E $1 billion fixed-to-fixed reset rate junior subordinated notes offering The 7.375% fixed-to-fixed reset rate junior subordinated notes are due 2055
September 13, 2024 Experience Big Lots chapter 11 filing, $707.5 million DIP financing and stalking horse APA We are advising Big Lots in connection with the restructuring
September 12, 2024 Experience SS&C Technologies $670 million acquisition of Battea-Class Action Services We are advising SS&C on the transaction
September 11, 2024 Experience McCourt Partners joint venture for Phoenix development project We advised McCourt Partners on the joint venture
September 11, 2024 Experience Payoneer Global tender offer for warrants We advised Payoneer on the tender offer